Filter By Category

Insights

Advancing Diversity, Equity, and Inclusion at IV

Learn more about DEI at IV and meet the council.

Read More

Insights

Bloomberg Businessweek’s “Hello World” Meets Nathan Myhrvold

Nathan Myhrvold is the subject of the latest "Hello World" episode.

Read More

Insights

IV’s Global Good Fund: A Legacy of Impact Invention

Building on a decade of success, IV is pleased to announce that Global Good projects have transitioned to the Bill & Melinda Gates Foundation and Gates Ventures.

Read More

Press Releases

Intellectual Ventures and Toler Law Group Collaborate to Give High-Growth Private Software Technology Companies Valuable Access to Patent Portfolio

New patent licensing program allows select software and application technology services companies greater access to IV’s vast patent portfolio.

Read More

Press Releases

Mangata Networks Selected by 5G Open Innovation Lab to Help Drive Early Adoption and Innovation of 5G Technology

Mangata Networks to Provide Affordable High Capacity 5G Over Satellite Global Solutions

Read More

Press Releases

Intellectual Ventures Names Arvin Patel to its Invention Investment Fund as Chief Operating Officer

IP industry veteran to lead commercialization strategy and execution, business development.

Read More

Press Releases

radiusIP, Inc. and Intellectual Ventures Announce Licensing Collaboration

The new patent licensing program will allow select companies in the IoT space access IV’s unparalleled patent portfolio.

Read More

Publications

An energy-efficient pathway to turbulent drag reduction

Deep Science Fund research published in Nature Communications.

Read More

Publications

New Prototype Screened Doors and Windows for Excluding Mosquitoes from Houses: A Pilot Study in Rural Gambia.

With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.

Read More

Publications

Automated microscopy for routine malaria diagnosis: a field comparison on Giemsa-stained blood films in Peru.

Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.

Read More

Publications

Polydisperse emulsion digital assay to enhance time to detection and extend dynamic range in bacterial cultures enabled by a statistical framework.

Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.

Read More

Media Coverage

Hertz Foundation Announces $5 Million Fellowship Gift Honoring Inventor and Entrepreneur Nathan Myhrvold

The Hertz Foundation

The Fannie and John Hertz Foundation, a non-profit organization dedicated to building a stronger nation through science and technology leadership, today announced a new fellowship honoring Dr. Nathan Myhrvold.

Read More

Media Coverage

This AI system will completely change your experience at sporting events

ZDNet

Thanks to spinout Evolv, the long security line at stadiums across the country may well be a thing of the past.

Read More

Media Coverage

Former Seattle Seahawks receiver Doug Baldwin standing out as tech CEO

ESPN

In-depth profile looking at the career of Doug Baldwin, CEO of IV spinout Ventrk.

Read More

Media Coverage

Bill Gates’ company TerraPower raises $750 million for nuclear energy and medicine innovation

CNBC

IV spinout TerraPower announces a massive equity raise of at least $750 million.

Read More

Popular Tags

inventors invention global good nathan myhrvold stem iv lab licensing secondary market spinouts patent reform historical global health u.s. adriane brown economy invention science fund litigation edward jung commercialization patent policy portfolio partner idf c-suite isf
We use cookies on this website to enhance your browser experience and to analyze your traffic. To learn more about cookies and how we use them view our cookie policy. By continuing to use our website you consent to the use of cookies.